Earnings NewsHealthcareSagent Pharmaceuticals (NASDAQ:SGNT): Q1 EPS of $0.34. Revenue of $60.2M beats by $4.89M. (PR)May 06, 2013 7:17 AM ETSagent Pharmaceuticals (SGNT) StockSGNTBy: Gaurav Batavia, SA News EditorSagent Pharmaceuticals (NASDAQ:SGNT): Q1 EPS of $0.34. Revenue of $60.2M beats by $4.89M. (PR)Recommended For YouMore Trending NewsSee More »Related StocksSymbolLast Price% ChgSGNT--Sagent PharmaceuticalsTrending AnalysisTrending News